Botanical species · safety record

Geranium pratense

The EFSA Compendium of Botanicals holds 6 constituent measurements and 1 adverse-effect record for Geranium pratense. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Geranium pratense L.

6Constituent measurements

1Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Gallotannins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Gallic acid	Live plants	Solvent extraction	2.4 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Tannins	Roots and other underground parts	Solvent extraction	≤ 34 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Tannins	Aerial part of plants	Solvent extraction	≥ 12 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Tannins	Aerial part of plants	Solvent extraction	≤ 20 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Tannins	Roots and other underground parts	Solvent extraction	≥ 19 Percent	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Aerial part of plants	Solvent extraction	House mouse (as animal)	In vitro	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Buckova, A., Leifertova, I., Natherova, L. Content of tannins in Geranium pratense. II. Cesko-slovenska farmacie, 1965, p. 406-409.
Kobayashi, K., Baba, E., Fushiya, S., Takano, F., Batkhuu, J., Dash, T., Sanchir, C., Yoshizaki, F. Screening of mongolian plants for influence on amylase activity in mouse plasma and gastrointestinal tube . Biological & pharmaceutical bulletin, 2003, vol. 26, no. 7, p. 1045-1048.
Xie, Song., Song, Liang-ke., Wan, Jun., Tong, Zhi-ping., Tan, Rui., Liu, Xiao-zhen. Determination of shikimic acid and gallic acid in Geranium pratense by HPLC. Zhongchengyao, 2014, p. 2554-2556.
Akdemir, ZS., Tatli, II., Saracoglu, I., Ismailoglu, UB., Sahin-Erdemli, I., Calis, I. Polyphenolic compounds from Geranium pratense and their free radical scavenging activities. PHYTOCHEMISTRY, 2001, vol. 56, no. 2, p. 189-193. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature